A conversation with Dr. Michael LaQuaglia, Chief of Pediatric Surgery at Memorial Sloan Kettering When a child is diagnosed with neuroblastoma, surgery is often one of the first things families ask about. What kind of surgery will be needed? Can the tumor be fully removed? What are the risks—and what comes next?

For families navigating a neuroblastoma diagnosis, one of the most confusing aspects is understanding the difference between stage and risk classification. Many assume that all Stage 4 neuroblastoma cases are the same, but the reality is much more complex—and personal.

Over the past six months, Shir for Life’s International Neuroblastoma Webinar Series has brought together more than 800 participants from 41 countries, creating a powerful global network of parents, doctors, researchers, and advocates. Another 800+ viewers have since watched these sessions on demand—proof of how needed and valued this resource is. Each month, we’ve tackled some of the most pressing topics in neuroblastoma, led by world-renowned experts and anchored in practi